Eagle Strategies’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,868
Closed -$376K 214
2024
Q4
$376K Sell
2,868
-1,668
-37% -$234K 0.07% 157
2024
Q3
$707K Sell
4,536
-569
-11% -$91.8K 0.13% 111
2024
Q2
$796K Buy
+5,105
New +$768K 0.15% 106
2024
Q1
Sell
-4,521
Closed -$609K 270
2023
Q4
$609K Buy
4,521
+15
+0.3% +$1.95K 0.13% 110
2023
Q3
$610K Buy
4,506
+921
+26% +$126K 0.15% 106
2023
Q2
$513K Buy
3,585
+114
+3% +$16.8K 0.12% 116
2023
Q1
$482K Buy
3,471
+409
+13% +$55K 0.12% 113
2022
Q4
$415K Buy
3,062
+577
+23% +$72.4K 0.12% 109
2022
Q3
$273K Buy
+2,485
New +$315K 0.14% 84

Other funds holding AZN